The U.S. Supreme Court has been relatively unfriendly to those seeking strong patent protection. Indeed, the historical pendulum has swung against patents at the high court over the past decade.

Profound questions of patent law were again center stage in front of the justices in the Myriad argument this past week. This provided a superb opportunity to evaluate the current climate at the court. It is probable that Myriad will be the third time in three years the court strikes down a substantial category of patents as "ineligible" for patenting. Yet, unexpectedly, the oral argument provided reasons to anticipate a less patent-skeptical court in the future.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]